AstraZeneca PLC yesterday announced that it would invest an additional NT$1 billion (US$32.6 million) in Taiwan over the next three years as it gears up to launch 10 new medicines by 2021.
The investment would help the company strengthen its bond with Taiwan, create 140 high-quality scientific jobs and increase its local workforce to 430, the company said.
The expansion would also support an additional 1,000 jobs through contract manufacturing, AstraZeneca Taiwan Ltd general manager Simon Manners told a news conference in Taipei.
The investment would raise the company’s average annual clinical research budget in Taiwan nearly threefold from NT$230 million to more than NT$600 million by 2021.
The company has also inked a letter of intent with BioHub Taiwan to collaborate with the biotechnology start-up incubator in the National Biotechnology Research Park in Taipei’s Nangang District (南港).
AstraZeneca would also collaborate with the Program for Translational Innovation of Biopharmaceutical Development-Technology Supporting Platform Axis, a program led by the science, economic and health ministries to accelerate the commercialization of technologies through effective integration of resources and infrastructure.
In the past five years, the company has invested more than NT$1.4 billion in clinical studies in Taiwan to develop medicines that suit the local genetic profile and treat the leading causes of death.
The company ranks first among its global peers in clinical trials on lung cancer, which has a disproportionately high occurrence rate in Taiwan.
These collaborations represent the company’s commitment to Taiwanese and would support the development of innovative solutions to healthcare challenges, Manners said.
It would also cultivate local talent and raise Taiwan’s profile as a biomedical development hub, he added.
The nation’s exemplary National Health Insurance (NHI) system and its healthcare infrastructure make it the ideal destination to conduct clinical studies and scientific research, medical international vice president Alexander Bedenkov said.
Apart from drug development, the company has initiated two healthcare delivery partnerships with local experts and start-ups to support the nation’s estimated 2 million asthma and 2 million diabetes patients.
“The partnerships we have initiated, such as Healthy Lung and Early Action in Diabetes, aim to improve and prolong patients’ lives and reduce healthcare expenditure,” Asia area president Joris Silon said.
While the Food and Drug Administration’s drug approval process has been efficient in granting priority review to three out of the 10 medicines set to be launched by 2021, the company hopes that its conversations with the government on NHI reimbursement could proceed at a faster pace, Manners said.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the